Investing in frontier technologies that elevate mental health and wellness.
INVESTMENT FOCUS
Psychedelics & New Compounds
Neurotech & BCI
Precision Psychiatry
Digital Therapeutics
PURPOSE
We are a community-focused fund & syndicate that provides capital and support to the best and most innovative companies that align healing, responsibility, and profitability. We can end mental illnesses.
INVESTMENT FOCUS
We invest in new categories that will revolutionize how mental health is treated.
PSYCHEDELIC MEDICINE
& NEW COMPOUNDS
Psychedelic therapy includes psychedelics (i.e. psilocybin, MDMA, DMT, ketamine) or novel compounds, and can be paired with talk therapy to treat conditions including depression, addiction, PTSD, and more.
NEUROTECH &
HUMAN AUGMENTATION
Direction connection of technical components with the brain and nervous system are addressing mental health disorders and neurological diseases
PRECISION PSYCHIATRY
Paradigm of clinical care shifting from general approach for large populations to individual-based deep knowledge of clinical and biological characteristics
DIGITAL THERAPEUTICS
Software applications that help patients treat, prevent, or manage a disease, and have a proven clinical benefit
INVESTMENTS
MOTIF NEUROTECH
Minimally invasive bioelectronic solutions for TRD
STEALTH NEUROTECH
Non-invasive treatment for mental health
STEALTH MARKETPLACE
Marketplace for transformational mental health modalities
We're donating 4.19% of our profit to psychedelic non-profits and indigenous communities since we are standing on the shoulders of giants.
PEOPLE
Greg Kubin
Greg is a community builder, investor, founder. He is a co-host of Business Trip, a podcast about psychedelic entrepreneurship. Over 15 investments in psychedelic medicine and mental health companies. Co-founded HelloSponsor, a SaaS sponsorship platform (AngelPad '15). Ex-Morgan Stanley, Viacom.
Matias Serebrinsky
Matias is an investor, founder, operator and startup ecosystem builder. He previously led NVIDIA Inception North America, a startup accelerator for AI companies. Before that, he co-founded CookUnity, raising $23m from Collaborative Fund, IDC Ventures, and others. Matias is the co-host of Business Trip.
Dina Burkitbayeva
Dina was one of the first investors in psychedelic therapeutics space and
is on the founding team of the largest psychedelic research center. Dina is also a serial entrepreneur, angel investor (Coinbase, Boom Supersonic, Mattermost), ex-McKinsey / J.P. Morgan, MBA Harvard Business School and MS in Psychology at CIIS.
Caitlin Ner
Caitlin is a chief of staff, community builder, and operator. She previously executed growth and operations at Cerebral and alternative investing and asset management at BlackRock. 9 years of mental health event management and project development. Caitlin is ex-Harvard in Economics and Computer Science.
Building a company that’s elevating mental health and wellness or looking to get involved as an investor?
SEND US AN EMAIL
